drugset

drugset / Trial / NCT00399425

Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients

NCT00399425 ↗

Phase 2/3 Terminated 84 enrolled Spanish National Health System Carlos III Health Institute · collab Rovi Pharmaceuticals Laboratories · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the efficacy of bemiparin (low molecular weight heparin) for 3 months in the treatment of chronic foot ulcers in diabetic patients.

Timeline

Start: 2001-06
Primary completion: —
Completion: 2004-04

Publications

Background Rullan M, Cerda L, Frontera G, Llobera J, Masmiquel L, Olea JL. [Triple-blind clinical trial with placebo control to evaluate the efficacy of a heparin of low molecular weight (bemiparin) for treating slow-responding ulcers in diabetic foot in primary care]. Aten Primaria. 2003 May 15;31(8):539-44. doi: 10.1016/s0212-6567(03)70729-x. Spanish.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bemiparin	Other / unclassified	—	—

Indications